BACKGROUND: Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this epidemic. The initial XDR-tuberculosis report from South Africa suggested transmission is an important factor, but detailed epidemiologic and molecular analyses were not available for further characterization. METHODS: We performed a retrospective, observational study among XDR-tuberculosis patients to identify hospital-associated epidemiologic links. We used spoligotyping, IS6110-based restriction fragment-length polymorphism analysis, and sequencing of resistance-determining regions to identify clusters. Social network analysis was used to construct transmission networks among genotypically clustered patients. RESULTS: Among 148 XDR-tuberculosis patients, 98% were infected with human immunodeficiency virus (HIV), and 59% had smear-positive tuberculosis. Nearly all (93%) were hospitalized while infectious with XDR-tuberculosis (median duration, 15 days; interquartile range: 10-25 days). Genotyping identified a predominant cluster comprising 96% of isolates. Epidemiologic links were identified for 82% of patients; social network analysis demonstrated multiple generations of transmission across a highly interconnected network. CONCLUSIONS: The XDR-tuberculosis epidemic in Tugela Ferry, South Africa, has been highly clonal. However, the epidemic is not the result of a point-source outbreak; rather, a high degree of interconnectedness allowed multiple generations of nosocomial transmission. Similar to the outbreaks of multidrug-resistant tuberculosis in the 1990s, poor infection control, delayed diagnosis, and a high HIV prevalence facilitated transmission. Important lessons from those outbreaks must be applied to stem further expansion of this epidemic.
BACKGROUND: Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this epidemic. The initial XDR-tuberculosis report from South Africa suggested transmission is an important factor, but detailed epidemiologic and molecular analyses were not available for further characterization. METHODS: We performed a retrospective, observational study among XDR-tuberculosispatients to identify hospital-associated epidemiologic links. We used spoligotyping, IS6110-based restriction fragment-length polymorphism analysis, and sequencing of resistance-determining regions to identify clusters. Social network analysis was used to construct transmission networks among genotypically clustered patients. RESULTS: Among 148 XDR-tuberculosispatients, 98% were infected with human immunodeficiency virus (HIV), and 59% had smear-positive tuberculosis. Nearly all (93%) were hospitalized while infectious with XDR-tuberculosis (median duration, 15 days; interquartile range: 10-25 days). Genotyping identified a predominant cluster comprising 96% of isolates. Epidemiologic links were identified for 82% of patients; social network analysis demonstrated multiple generations of transmission across a highly interconnected network. CONCLUSIONS: The XDR-tuberculosis epidemic in Tugela Ferry, South Africa, has been highly clonal. However, the epidemic is not the result of a point-source outbreak; rather, a high degree of interconnectedness allowed multiple generations of nosocomial transmission. Similar to the outbreaks of multidrug-resistant tuberculosis in the 1990s, poor infection control, delayed diagnosis, and a high HIV prevalence facilitated transmission. Important lessons from those outbreaks must be applied to stem further expansion of this epidemic.
Authors: G Di Perri; M Cruciani; M C Danzi; R Luzzati; G De Checchi; M Malena; S Pizzighella; R Mazzi; M Solbiati; E Concia Journal: Lancet Date: 1989 Dec 23-30 Impact factor: 79.321
Authors: P J Bifani; B B Plikaytis; V Kapur; K Stockbauer; X Pan; M L Lutfey; S L Moghazeh; W Eisner; T M Daniel; M H Kaplan; J T Crawford; J M Musser; B N Kreiswirth Journal: JAMA Date: 1996-02-14 Impact factor: 56.272
Authors: C L Daley; P M Small; G F Schecter; G K Schoolnik; R A McAdam; W R Jacobs; P C Hopewell Journal: N Engl J Med Date: 1992-01-23 Impact factor: 91.245
Authors: Peter D McElroy; Timothy R Sterling; Cynthia R Driver; Barry Kreiswirth; Charles L Woodley; Wendy A Cronin; Darryl X Hardge; Kenneth L Shilkret; Renee Ridzon Journal: Emerg Infect Dis Date: 2002-11 Impact factor: 6.883
Authors: Pablo E Campos; Pedro G Suarez; Jorge Sanchez; David Zavala; Jorge Arevalo; Eduardo Ticona; Charles M Nolan; Thomas M Hooton; King K Holmes Journal: Emerg Infect Dis Date: 2003-12 Impact factor: 6.883
Authors: Bourahima Kone; Anou M Somboro; Jane L Holl; Bocar Baya; Antieme Acg Togo; Yeya Dit Sadio Sarro; Bassirou Diarra; Ousmane Kodio; Robert L Murphy; William Bishai; Mamoudou Maiga; Seydou Doumbia Journal: Int J Mol Epidemiol Genet Date: 2020-06-15
Authors: Sara C Auld; N Sarita Shah; Barun Mathema; Tyler S Brown; Nazir Ismail; Shaheed Vally Omar; James C M Brust; Kristin N Nelson; Salim Allana; Angela Campbell; Koleka Mlisana; Pravi Moodley; Neel R Gandhi Journal: Eur Respir J Date: 2018-10-18 Impact factor: 16.671
Authors: Gabriel Chamie; Bonnie Wandera; Carina Marquez; Midori Kato-Maeda; Moses R Kamya; Diane V Havlir; Edwin D Charlebois Journal: Trop Med Int Health Date: 2015-02-04 Impact factor: 2.622
Authors: Maia Kipiani; Veriko Mirtskhulava; Nestani Tukvadze; Matthew Magee; Henry M Blumberg; Russell R Kempker Journal: Clin Infect Dis Date: 2014-08-04 Impact factor: 9.079